Founder of NanoValent Pharmaceuticals, Inc., James C. Hamilton is Vice President & Head-Clinical Development at Arrowhead Pharmaceuticals, Inc.

In his past career he was Chief Executive Officer at Calando Pharmaceuticals, Inc.

Dr. Hamilton received an undergraduate degree from Miami University and an MBA and a doctorate from The Ohio State University.